Healthcare provider profile · identity verified

Clarence E Coker, MD

Family Practice · LEXINGTON, SC · NPI 1003891508

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Pravastatin Sodium	Pravastatin Sodium	584	162
Levothyroxine Sodium	Levothyroxine Sodium	456	110
Amlodipine Besylate	Amlodipine Besylate	428	113
Lisinopril	Lisinopril	328	91
Gabapentin	Gabapentin	270	78
Omeprazole	Omeprazole	264	69
Tramadol Hcl	Tramadol Hcl	245	43
Metoprolol Succinate	Metoprolol Succinate	221	58
Allopurinol	Allopurinol	220	53
Tamsulosin Hcl	Tamsulosin Hcl	220	58
Losartan Potassium	Losartan Potassium	218	59
Metformin Hcl Er	Metformin Hcl	199	50
Rosuvastatin Calcium	Rosuvastatin Calcium	191	55
Pantoprazole Sodium	Pantoprazole Sodium	188	60
Trazodone Hcl	Trazodone Hcl	153	37
Glipizide Er	Glipizide	151	38
Hydrochlorothiazide	Hydrochlorothiazide	150	41
Duloxetine Hcl	Duloxetine Hcl	142	29
Famotidine	Famotidine	138	41
Metformin Hcl	Metformin Hcl	136	37
Fluticasone Propionate	Fluticasone Propionate	126	47
Sertraline Hcl	Sertraline Hcl	126	32
Doxycycline Hyclate	Doxycycline Hyclate	124	101
Escitalopram Oxalate	Escitalopram Oxalate	124	35
Furosemide	Furosemide	115	42
Farxiga	Dapagliflozin Propanediol	113	23
Buspirone Hcl	Buspirone Hcl	108	31
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	107	29
Telmisartan	Telmisartan	107	21
Clonazepam	Clonazepam	106	18
Atorvastatin Calcium	Atorvastatin Calcium	104	29
Ozempic	Semaglutide	102	20
Meloxicam	Meloxicam	99	28
Montelukast Sodium	Montelukast Sodium	99	24
Alprazolam	Alprazolam	95	20
Esomeprazole Magnesium	Esomeprazole Magnesium	86	25
Jardiance	Empagliflozin	83	15
Lorazepam	Lorazepam	75	15
Citalopram Hbr	Citalopram Hydrobromide	68	15
Diclofenac Sodium	Diclofenac Sodium	65	38
Mupirocin	Mupirocin	65	43
Atenolol	Atenolol	62	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	62	18
Myrbetriq	Mirabegron	62	14
Albuterol Sulfate Hfa	Albuterol Sulfate	61	22
Potassium Chloride	Potassium Chloride	60	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	55	44
Mirtazapine	Mirtazapine	55	13
Synthroid	Levothyroxine Sodium	53	14
Zaleplon	Zaleplon	53	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	18
Mounjaro	Tirzepatide	49	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	49	12
Glimepiride	Glimepiride	48	12
Januvia	Sitagliptin Phosphate	47	13
Metoprolol Tartrate	Metoprolol Tartrate	47	14
Clopidogrel	Clopidogrel Bisulfate	46	13
Pregabalin	Pregabalin	46	suppressed
Prednisone	Prednisone	45	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	42	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	13
Warfarin Sodium	Warfarin Sodium	37	11
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Eliquis	Apixaban	36	12
Benazepril Hcl	Benazepril Hcl	35	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	35	suppressed
Ezetimibe	Ezetimibe	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Colchicine	Colchicine	33	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	32	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Trulicity	Dulaglutide	32	suppressed
Valacyclovir	Valacyclovir Hcl	32	17
Bupropion Xl	Bupropion Hcl	31	suppressed
Nebivolol Hcl	Nebivolol Hcl	30	suppressed
Azithromycin	Azithromycin	29	25
Irbesartan	Irbesartan	29	suppressed
Fenofibrate	Fenofibrate	28	suppressed
Liothyronine Sodium	Liothyronine Sodium	28	suppressed
Simvastatin	Simvastatin	27	suppressed
Carvedilol	Carvedilol	26	suppressed
Diazepam	Diazepam	26	suppressed
Febuxostat	Febuxostat	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	23
Ondansetron Odt	Ondansetron	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	19
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Cefadroxil	Cefadroxil	23	21
Terazosin Hcl	Terazosin Hcl	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Finasteride	Finasteride	22	suppressed
Fluconazole	Fluconazole	22	15
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Amantadine	Amantadine Hcl	21	suppressed
Armour Thyroid	Thyroid,pork	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	12
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Triazolam	Triazolam	19	suppressed
Naproxen	Naproxen	18	13
Carbamazepine Er	Carbamazepine	17	suppressed
Estradiol	Estradiol	17	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Belsomra	Suvorexant	16	suppressed
Mirabegron Er	Mirabegron	16	suppressed
Armodafinil	Armodafinil	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	11
Modafinil	Modafinil	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Topiramate	Topiramate	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	12
Climara Pro	Estradiol/Levonorgestrel	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Icosapent Ethyl	Icosapent Ethyl	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Tiagabine Hcl	Tiagabine Hcl	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	13	suppressed
Valsartan	Valsartan	13	suppressed
Amoxicillin	Amoxicillin	12	11
Levetiracetam	Levetiracetam	12	suppressed
Linzess	Linaclotide	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Nystatin	Nystatin	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Ramipril	Ramipril	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error